Development
Zeo ScientifiX, Inc.
ZEOX
$1.96
-$0.01-0.51%
OTC PK
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -1.50% | -28.75% | -51.27% | -33.07% | -13.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.50% | -28.75% | -51.27% | -33.07% | -13.36% |
| Cost of Revenue | -50.63% | -22.23% | -14.48% | -30.05% | 150.89% |
| Gross Profit | 9.77% | -29.66% | -54.16% | -33.39% | -24.66% |
| SG&A Expenses | -44.63% | -41.30% | -7.57% | 1.64% | 73.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.98% | -40.41% | -7.86% | 0.18% | 76.60% |
| Operating Income | 64.71% | 47.64% | -52.01% | -32.59% | -233.99% |
| Income Before Tax | 65.31% | 40.69% | -36.77% | -35.01% | -228.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 65.31% | 40.69% | -36.77% | -35.01% | -228.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.87% | 40.69% | -36.77% | -35.01% | -215.11% |
| EBIT | 64.71% | 47.64% | -52.01% | -32.59% | -233.99% |
| EBITDA | 62.10% | 52.72% | -41.69% | -24.16% | -211.20% |
| EPS Basic | 67.02% | 54.62% | -1.48% | -2.00% | -174.07% |
| Normalized Basic EPS | 62.95% | 56.63% | -1.48% | -2.00% | -173.16% |
| EPS Diluted | 67.02% | 54.62% | -1.48% | -2.00% | -11.63% |
| Normalized Diluted EPS | 62.95% | 56.63% | -1.48% | -2.00% | -173.16% |
| Average Basic Shares Outstanding | 23.65% | 30.69% | 34.80% | 32.35% | 1.89% |
| Average Diluted Shares Outstanding | 23.65% | 30.69% | 34.80% | 32.35% | 1.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |